HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Internal Tourniquet Provides Deep Wound Hemorrhage Control

By HospiMedica International staff writers
Posted on 25 Jan 2010
Image: The TourniCath device (Photo courtesy CardioCommand).
Image: The TourniCath device (Photo courtesy CardioCommand).
An innovative device that is inserted into a bullet wound and then inflated to apply pressure directly along the bullet's path helps control blood loss.

The TourniCath device is a balloon tamponade designed to control exsanguinating hemorrhage that is not manageable by conventional external means such as direct pressure, clotting agents, bandages, and tourniquets. The device works by internal wound track compression using a cylindrical, doubled walled, inflatable balloon. The balloon is made of two wall layers of material: the outer wall is nylon coated on the inside with polyurethane; the inner wall is a layer of soft polyurethane. The design makes the balloon resistant to punctures from sharp objects, like shrapnel, that might be inside the wound, and also helps the balloon to conform to the shape of the wound and compress it.

Designed for wounds that produce profuse hemorrhage due to a deep penetrating trauma in the groin, pelvis, shoulder, or axilla areas, the TourniCath has a smooth rounded tip and a smooth outer sheath covering the rolled balloon. Once inserted into the wound track--through either the entry or the exit wounds-and the outer sheath removed, the balloon is then inflated to a pressure sufficient to tamponade internal bleeding (usually 90 mmHg to 150 mmHg). The maximum potential inflation volume of the cylindrical balloon is 400 mL, and the dimensions at maximum volume are 20 cm in length and 5 cm in diameter. The TourniCath is under development by CardioCommand (Tampa, FL, USA), and is not indicated for abdominal or thoracic wounds. The Tournicath Device is not currently approved by the US. Food and Drug Administration (FDA) and is therefore not available for sale in the United States.

Related Links:

CardioCommand




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Fetal Monitor
BT-380
Medical-Grade Display
HL2316SHTB

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more